PubRank

Evo Alemao

Author PubWeight™ 15.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Cost effectiveness in the Danish health care of ezetemibe co-administration compared to simvastatin]. Ugeskr Laeger 2008 2.03
2 Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clin Ther 2007 1.34
3 The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease. Am J Cardiovasc Drugs 2006 1.02
4 Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study. Curr Med Res Opin 2005 1.02
5 Cost, morbidity, and control of asthma in Hungary: The Hunair Study. J Asthma 2003 1.02
6 A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma. Clin Ther 2002 1.00
7 Cholesterol goal attainment in patients with coronary heart disease and elevated coronary risk: results of the Hong Kong hospital audit study. Value Health 2008 0.96
8 Association between achieving treatment goals for lipid-lowering and cardiovascular events in real clinical practice. Eur J Cardiovasc Prev Rehabil 2005 0.93
9 Determinants of medicare all-cause costs among elderly patients with renal cell carcinoma. J Manag Care Pharm 2011 0.90
10 Cost of care for patients treated with lipid-lowering drugs. Pharmacoeconomics 2004 0.86
11 Real-world effectiveness of lipid-lowering therapy in male and female outpatients with coronary heart disease: relation to pre-treatment low-density lipoprotein-cholesterol, pre-treatment coronary heart disease risk, and other factors. Eur J Cardiovasc Prev Rehabil 2005 0.84
12 Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemia. Pharmacoeconomics 2004 0.80
13 Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway. Pharmacoeconomics 2004 0.80
14 Cost effectiveness of adding ezetimibe to atorvastatin therapy in patients not at cholesterol treatment goal in Canada. Pharmacoeconomics 2006 0.78
15 Impact of new Joint British Societies' (JBS 2) guidelines on prevention of cardiovascular disease: evaluation of serum total cholesterol goal achievement in UK clinical practice. Curr Med Res Opin 2007 0.78
16 Statins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO study. Curr Med Res Opin 2004 0.78
17 National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom. Int J Cardiol 2003 0.75
18 Projected coronary heart disease risk benefit with ezetimibe. Atherosclerosis 2004 0.75
19 [Cholesterol goal attainment with lipid lowering drugs. The COMETA Mexico Trial]. Gac Med Mex 2004 0.75